Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial

Early decrease of ctDNA ratio can provide prognostic information early in the management of patients, allowing a more accurate information to patients and an early preparation for CRS (prehabilitation).

Authors

Institutions

Publication Details

Journal
Gynecologic Oncology
Published
2024-12-12
DOI
https://doi.org/10.1016/j.ygyno.2024.12.004
Citations
3
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.86
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial

Nadine Dohollou, Louise Benoit, Alexandra Léary, Cyriac Blonz et al.
3 citations
Gynecologic Oncology
Cancer Genomics and Diagnostics
0.86
article

Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial

Nadine Dohollou, Louise Benoit, Alexandra Léary, Cyriac Blonz, Sophie Abadie‐Lacourtoisie, Valérie Taly, Camille Brochard, Emmanuelle Malaurie, Gwénaël Ferron, Coraline Dubot, Coriolan Lebreton, Anne‐Sophie Bats, Hélène Blons, Éric Pujade-Lauraine, Henri Azaïs, I. L. Ray-Coquard, Jean‐Emmanuel Kurtz, Pierre Laurent‐Puig, Étienne Rouleau, Laurence Venat, Benoît You, C. Louvet, Laure Favier
article en
3 citations

Abstract

Early decrease of ctDNA ratio can provide prognostic information early in the management of patients, allowing a more accurate information to patients and an early preparation for CRS (prehabilitation).

Gynecologic OncologyVol. 192
Délégation Paris 5 (FR), Inserm (FR), Université Paris Cité (FR), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Institut de Cancérologie Strasbourg (FR), Institute Mutualiste Montsouris (FR), Centre de Recherche des Cordeliers (FR), Centre Georges François Leclerc (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Hôpital Européen Georges-Pompidou (FR), Centre Léon Bérard (FR), Institut de Cancérologie de l'Ouest (FR), Hôpital Européen (FR), Hôpital René Huguenin (FR), Polyclinique de Bordeaux-Tondu (FR), Institut Claudius Regaud (FR), Institut Bergonié (FR), Arcagy Gineco (FR), Hôpital privé du Confluent (FR), Hôpital Universitaire Dupuytren (FR), Hôpital Intercommunal de Créteil (FR)
Good health and well-being
Openalex Percentile: Top 24%
Cancer Genomics and Diagnostics
0.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.